FDA Should Add Age Modification To Antidepressant Suicidality Warning, Committee Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Current “black box” warning on pediatric suicidality should be expanded to note that risk does not appear to extend beyond young adults, with possible protective effects in elderly populations.